Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer. - Wikidata - wikimedia - TriplyDB

Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.

Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.

http://www.wikidata.org/entity/Q37610511

about

Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway.Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer

P2860

Q50675628-DC72FF8E-F9DD-4CDC-B5F9-6D102404C281 Q58705089-2E2AD8C7-9105-444A-82DF-B6CD32221E01

P2860

Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.

http://www.wikidata.org/entity/Q37610511

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Change in Psoas Muscle Volume ...... uscle-Invasive Bladder Cancer.

@en

Change in Psoas Muscle Volume ...... uscle-Invasive Bladder Cancer.

@nl

type

label

Change in Psoas Muscle Volume ...... uscle-Invasive Bladder Cancer.

@en

Change in Psoas Muscle Volume ...... uscle-Invasive Bladder Cancer.

@nl

prefLabel

Change in Psoas Muscle Volume ...... uscle-Invasive Bladder Cancer.

@en

Change in Psoas Muscle Volume ...... uscle-Invasive Bladder Cancer.

@nl

P1433

Q37610511-599C2368-26AF-4034-84D7-08F87FE1CC05

P1476

Q37610511-17B4B516-6186-4019-99B5-863233850E90

P2093

Q37610511-1F11B304-34A6-49B8-9D7B-1DC1081137AB

Q37610511-1F4B447B-3E3F-4961-9FC1-457045731F88

Q37610511-4F803FBD-93F9-4ED0-A9ED-93E7D3BD167C

Q37610511-69B1703B-A247-4487-93E3-C636C90B2C57

Q37610511-77BA2708-B4F8-43EC-9303-4746F6C98E0E

Q37610511-7F10AA39-541B-4472-BE41-27281DE05797

Q37610511-81F8ED54-3EF3-406B-A0F5-DDF1728C0881

Q37610511-95C393E4-1073-408A-B9F9-033E6CE9FAAD

Q37610511-DC2CD7FB-5909-4C68-91EB-D72C2E77BFFC

P2860

Q37610511-04FC7BF8-60E5-4929-9DBD-8ACB4D33C5E9

Q37610511-1C96FFCF-40CA-4E83-A2A9-4A43B1B7630B

Q37610511-3300D52E-39D6-45E3-8D05-3AB34841BCBD

Q37610511-3FD1DE2C-FE23-4DFC-BC7B-FC5C4857A2BC

Q37610511-57411B7F-6466-4ED3-8C2B-DC8BF2AE6053

Q37610511-5DFAF50C-5839-4CB5-B97F-C8CC18958838

Q37610511-5FBC28D5-3C36-4C84-ACFC-B4A6E179F8A3

Q37610511-922BC154-CFD3-4DB6-96F2-261A49B7E9E7

Q37610511-C3FC75BE-8153-415A-89F5-86D91D6A46ED

Q37610511-C8460847-5BB7-4BEA-B38A-1496BE37EF16

P304

Q37610511-6CFEC58A-7EB4-46E4-9261-239C9046BFBF

P31

Q37610511-75E81AB2-404A-4507-AC7F-4FD4C3A0B4EB

P356

Q37610511-3B08268C-38CA-4945-B115-045E5FE27356

P433

Q37610511-DA805B3C-FB87-4261-BEDB-9C3DB7E15CE0

P478

Q37610511-0B617D66-1A48-4668-B743-B0A4EE237C04

P577

Q37610511-095FA159-84F2-4B7A-900C-8AA461929147

P698

Q37610511-289E9758-35FF-4837-BD3A-DE41542B8AD5

P921

Q37610511-FA60E4F2-379A-46DE-8B5F-83B004C78494

P932

Q37610511-A689F5B1-A089-435F-8E76-4D6AFCF1F0CD

P356

P1433

Bladder Cancer (Amsterdam, Netherlands)

P1476

Change in Psoas Muscle Volume ...... uscle-Invasive Bladder Cancer.

@en

P2093

Andrew Stephenson

http://www.w3.org/2001/XMLSchema#string

Brian Rini

http://www.w3.org/2001/XMLSchema#string

Cesar Ercole

http://www.w3.org/2001/XMLSchema#string

Erick Remer

http://www.w3.org/2001/XMLSchema#string

Evan Kovac

http://www.w3.org/2001/XMLSchema#string

Homayoun Zargar

http://www.w3.org/2001/XMLSchema#string

Jorge A Garcia

http://www.w3.org/2001/XMLSchema#string

Nima Almassi

http://www.w3.org/2001/XMLSchema#string

Petros Grivas

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

The stress response to trauma and surgery.

Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer

Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery

Exercise-based pre-habilitation is feasible and effective in radical cystectomy pathways-secondary results from a randomized controlled trial.

Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.

Sarcopenia as a predictor of complications and survival following radical cystectomy.

Analytic morphomics, core muscle size, and surgical outcomes.

Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy.

P304

57-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/BLC-160080

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28149936

http://www.w3.org/2001/XMLSchema#string

P921

P932

5271424

http://www.w3.org/2001/XMLSchema#string